![1]()
News
Updated heart failure measures add newer meds
November 2, 2020
Updated measures for heart failure account for newer medications, drug titration in cardiac resynchronization therapy, and patient-reported outcomes.
![1]()
News
Echocardiography in AMI not associated with improved outcomes
October 30, 2020
Does the use of echocardiography have any association with outcomes in acute myocardial infarction (AMI)?
![1]()
News
Valvular disease and COVID-19 are a deadly mix; don’t delay intervention
October 27, 2020
International registry data make a strong case for not deferring valve interventions during pandemic.
![1]()
News
When should students resume sports after a COVID-19 diagnosis?
October 23, 2020
While many patients will be ready to gradually return to play after quarantining, cardiac symptoms should prompt additional evaluation.
![1]()
News
No mortality benefit after intensive glucose control once Hb A1c curves equalize
October 23, 2020
Is there a reduction in cardiovascular events in veterans with type 2 diabetes who were treated with intensive glucose control versus standard therapy at 15 years’ follow-up?
![1]()
News
Certain statins linked to lower mortality risk in patients admitted for sepsis
October 22, 2020
Statin use was associated with lower mortality, compared with no use, with hydrophilic and synthetic statins besting lipophilic and fungal-derived statins.
![1]()
News
Cardiogenic shock rate soars in COVID-positive ACS
October 21, 2020
In-hospital mortality was quadrupled in COVID-positive STEMI patients.
![1]()
News
NACMI: Clear benefit with PCI in STEMI COVID-19 patients
October 16, 2020
Angiography fell off but door-to-balloon times haven’t suffered, even with the pandemic, according to initial results from the North American registry.
News
Entresto halves renal events in preserved EF heart failure patients
October 15, 2020
The PARAGON-HF trial of sacubitril/valsartan in patients with heart failure with preserved ejection fraction didn’t meet its primary outcome but significantly improved a secondary renal endpoint.
![1]()
News
Empagliflozin cut PA pressures in heart failure patients
October 12, 2020
The drops in pulmonary artery pressure were modest but large enough to be clinically meaningful, they appeared quickly, and increased over time.
